The anti-neuroinflammation of erinacine A on LPS-induced Parkinson's disease in vivo and in vitro

被引：0
|
作者：
Chin, T. Y. [1 ]
Lee, S. L. [2 ]
Hsu, J. Y. [1 ]
Chen, T. C. [1 ]
机构：
[1] Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan, Taiwan
[2] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan
来源：
FEBS OPEN BIO | 2018年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P.09-052-M
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [1] Morin ameliorates rotenone-induced Parkinson's Disease in mice through anti-oxidation and anti-neuroinflammation
    Olubodun-Obadun, Taiwo
    Ishola, Ismaila
    Oluwafemi, Oluwadara
    Adeyemi, Oluwafunmilayo
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 149 - 150
  • [2] Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson's Disease
    Kang, Sora
    Noh, Youngjin
    Oh, Seung Jun
    Yoon, Hye Ji
    Im, Suyeol
    Kwon, Hung Taeck
    Pak, Youngmi Kim
    MOLECULES, 2023, 28 (24):
  • [3] Anti-neuroinflammation effect of zonisamide in early Parkinson's disease: A chronological PET study
    Matsudaira, Takashi
    Terada, Tatsuhiro
    Bunai, Tomoyasu
    Hashizume, Takanori
    Yokokura, Masamichi
    Takashima, Hirotsugu
    Konishi, Takashi
    Obi, Tomokazu
    Ouchi, Yasuomi
    NEUROLOGY, 2023, 100 (17)
  • [4] Glabridin reduces neuroinflammation by modulating inflammatory signals in LPS-induced in vitro and in vivo models
    Weng, Jiyu
    Wang, Ying
    Tan, Zekai
    Yuan, Yanghe
    Huang, Shiyuan
    Li, Zexi
    Li, Yiming
    Zhang, Lanyue
    Du, Zhiyun
    INFLAMMOPHARMACOLOGY, 2024, 32 (02) : 1159 - 1169
  • [5] Glabridin reduces neuroinflammation by modulating inflammatory signals in LPS-induced in vitro and in vivo models
    Jiyu Weng
    Ying Wang
    Zekai Tan
    Yanghe Yuan
    Shiyuan Huang
    Zexi Li
    Yiming Li
    Lanyue Zhang
    Zhiyun Du
    Inflammopharmacology, 2024, 32 : 1159 - 1169
  • [6] Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson's Disease
    Golembiowska, Krystyna
    Wardas, Jadwiga
    Noworyta-Sokolowska, Karolina
    Kaminska, Katarzyna
    Gorska, Anna
    NEUROTOXICITY RESEARCH, 2013, 24 (01) : 29 - 40
  • [7] Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease
    Krystyna Gołembiowska
    Jadwiga Wardas
    Karolina Noworyta-Sokołowska
    Katarzyna Kamińska
    Anna Górska
    Neurotoxicity Research, 2013, 24 : 29 - 40
  • [8] Development of in-vivo models of LPS-induced neuroinflammation and neurodegeneration
    Pugh, PL
    Swales, AG
    Vidgeon-Hart, MP
    Marshall, IC
    Smith, MI
    Al-Hasani, R
    Brown, M
    Wadsworth, G
    Tilling, LC
    Virley, DJ
    Upton, N
    Sunter, D
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 203 - 203
  • [9] Monascin exhibits neuroprotective effects in rotenone model of Parkinson's disease via antioxidation and anti-neuroinflammation
    Lin, Qiuyu
    Hou, Sen
    Dai, Yuyin
    Jiang, Nan
    Lin, Yingjie
    NEUROREPORT, 2020, 31 (09) : 637 - 643
  • [10] Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
    Fourrier, Celia
    Remus-Borel, Julie
    Greenhalgh, Andrew D.
    Guichardant, Michel
    Bernoud-Hubac, Nathalie
    Lagarde, Michel
    Joffre, Corinne
    Laye, Sophie
    JOURNAL OF NEUROINFLAMMATION, 2017, 14
12345